Skip to content
★ Sign in to follow
Krsnaa Diagnostics Limited logo

Krsnaa Diagnostics Limited Stock: price and insider trades · India

IN·Mcap ₹17.4BHealth Care

No insider purchase over the last 90 days. The latest, by Krsna Diagnostics (Mumbai) Private Limited, was filed 30 Dec 2024.

Krsnaa Diagnostics Limited: what insiders have been doing

Every trade that managers of Krsnaa Diagnostics Limited disclose to SEBI (PIT + SAST) is tracked on this page. The company sits in the Health Care sector. Nothing new has been filed by managers of Krsnaa Diagnostics Limited in twelve months, the latest record being from 30 December 2024.

Looking back to 2022, when coverage begins, insiders filed 13 purchases and no sales.

In the same sector, recent insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. also feature in our signals. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.

Insider Decl.
13
Thresholds
n/a
Buy Volume
€3M
13 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Krsna Diagnostics (Mumbai) Private Limited1 buy

Analyst consensus: bullish or bearish?

Analysts rate Krsnaa Diagnostics Limited Buy (bullish), based on 4 analysts. Average price target: ₹841.00.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 8,639 of 26,897 companies
60.5
score / 100
Value
52
Quality
69
FCF yld-4.4%
Earn yld5.8%
EV/EBITDA9.0x
ROE11%
Gross mgn69%
Net mgn13%
Debt/EBITDA2.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹535.50
Analyst consensus
4 analysts
Buy
₹682.00Target ₹841.00(+57%)₹994.00
Income statement
Revenue₹7.7B
Gross profit₹5.3B69% margin
EBITDA₹2.5B33% margin
Net income₹1B11.6% margin
Valuation
PER (trailing)18.1x
PER (forward)11.6x
P/Book1.8x
Beta0.02
Balance sheet & cash
Market cap₹17.4B
Total debt₹5.3B
Free Cash Flow-₹761.6M
Debt / Equity55%
Profitability & ownership
ROE10.9%
ROA5.9%
% insiders45.7%
% institutions13.5%
Last declaration on 30 December 2024
Declarations13 total
  • ▲
    Related company / holdingExecutives
    20M INR10SEBI
    22,929 shares@ ₹870.8886100.0% of flowEquity SharesSEBI:ba9b2821ff736ec01c3424d07d42155fe3551630
    Canonical exit: 27 Mar 2025 (T+90)
  • ▲
    Related company / holdingExecutives
    24M INR10SEBI
    45,000 shares@ ₹540.8573100.0% of flowEquity SharesSEBI:311962d8a16768723d9ccb0a9148a6b0d34705d3
    Canonical exit: 2 Sept 2024 (T+90)
  • ▲
    67M INR10SEBI
    130,000 shares@ ₹512.29100.0% of flowEquity SharesSEBI:986226e1fa49abb1c73ebaaff89afdd9304cd437
    Canonical exit: 11 Dec 2022 (T+90)
  • ▲
    Related company / holdingExecutives
    6M INR3SEBI
    10,000 shares@ ₹604.94218.1% of flowEquity SharesSEBI:b1c5aa50d50683df7c5f6acf865205190f73c292
    Canonical exit: 18 May 2022 (T+90)
  • ▲
    Related company / holdingExecutives
    5M INR3SEBI
    7,700 shares@ ₹603.25196.2% of flowEquity SharesSEBI:46439e50a53cf5e5d484c43ca7b5a2ad236754be
    Canonical exit: 19 May 2022 (T+90)
  • ▲
    Related company / holdingExecutives
    3M INR2SEBI
    5,288 shares@ ₹619.91644.4% of flowEquity SharesSEBI:09b3c0ae31d47de87fc163f101dc9879344dc267
    Canonical exit: 16 May 2022 (T+90)
  • ▲
    Related company / holdingExecutives
    6M INR3SEBI
    10,000 shares@ ₹615.16318.2% of flowEquity SharesSEBI:1c54bf04ddca10e401553ac72bbb8aa8239715ac
    Canonical exit: 17 May 2022 (T+90)
  • ▲
    Related company / holdingExecutives
    16M INR4SEBI
    25,000 shares@ ₹640.726921.1% of flowEquity SharesSEBI:69a27694b970fd0ad4dbef94714eafb7ea61d889
    Canonical exit: 15 May 2022 (T+90)
  • ▲
    Related company / holdingExecutives
    5M INR3SEBI
    7,159 shares@ ₹643.43346.1% of flowEquity SharesSEBI:671d183afc2f9bfd7da07662e1a240239b5cf411
    Canonical exit: 12 May 2022 (T+90)
  • ▲
    Related company / holdingExecutives
    1M INR2SEBI
    1,780 shares@ ₹652.09211.6% of flowEquity SharesSEBI:143945081357b14011468dc4883ca358cedcd024
    Canonical exit: 9 May 2022 (T+90)
  • ▲
    Related company / holdingExecutives
    33M INR6SEBI
    50,000 shares@ ₹658.804644.2% of flowEquity SharesSEBI:a76e10ed7db5f1ea892a09cd13329093c0583c10
    Canonical exit: 10 May 2022 (T+90)
  • ▲
    Related company / holdingExecutives
    56M INR10SEBI
    75,000 shares@ ₹743.87475.3% of flowEquity SharesSEBI:3c3afbb4d4f07e738329299fecd67f824a844ba0
    Canonical exit: 30 Mar 2022 (T+90)
  • ▲
    Related company / holdingExecutives
    18M INR4SEBI
    25,000 shares@ ₹727.58524.7% of flowEquity SharesSEBI:09acb44d03b374e7941b57a70ac421d682d85a46
    Canonical exit: 31 Mar 2022 (T+90)

13 of 13 declarations

About Krsnaa Diagnostics Limited

Krsnaa Diagnostics Limited is a company specializing in medical diagnostic services in India. It offers a range of laboratory tests and imaging services to enhance healthcare.